Cagli Barbara, Morelli Coppola Marco, Augelli Federica, Segreto Francesco, Tenna Stefania, Cogliandro Annalisa, Persichetti Paolo
Department of Plastic, Reconstructive and Aesthetic Surgery, Campus Bio-Medico University, Rome, Italy.
Department of Plastic Surgery and Burn Unit, Niguarda Hospital, Milan, Italy.
Aesthetic Plast Surg. 2022 Dec;46(6):2643-2654. doi: 10.1007/s00266-022-03001-7. Epub 2022 Jul 19.
Postmastectomy radiation therapy (PMRT) has a primary role in the treatment of locally advanced breast cancer; however, the most appropriate timing of irradiation in immediate tissue expander breast reconstruction (ITEBR) still remains unknown.
A retrospective review was performed on all women undergoing mastectomy and retropectoral ITEBR at Campus Bio-Medico University Hospital in Rome, Italy, between 2010 and 2019. The patients were categorized into three cohorts: patients undergoing PMRT with the tissue expander (TE) in situ, patients with PMRT delivered to the permanent implant (PI), patients who were not administered RT. Complications and failure rates were analysed and compared. Potential predictors of adverse outcomes were analysed.
Over 10 years, 183 patients underwent retropectoral ITEBR (55 PMRT-TE, 50 PMRT-PI, 78 no-PMRT). The three groups were well matched with respect to patient- and treatment-related factors (p > 0.05), with the exception of neoadjuvant chemotherapy and irradiation. The mean follow-up was, respectively, 4.58, 7 and 5.75 years. Radiotherapy either to the TE or to the PI was independently associated with failure and conversion to autologous procedures (p < 0.0001). Failure rate was significantly higher when TE was irradiated (p = 0.03). PMRT was associated with severe capsular contracture development (p < 0.00001), the odds being higher when irradiation was delivered after implant exchange (p = 0.04). Increased BMI was significantly associated with failure.
When PMRT is delivered to the TE, the risk of failure is higher (OR 2.77); when the PI is irradiated, reconstruction will more likely be affected by severe capsular contracture (OR 2.7). However, considering that the overall risk of severe capsular contracture correlated to PMRT is higher than failure, we believe that irradiation should be delivered to the TE. Performing a proper capsuloplasty at the time of implant exchange, indeed, allows to correct the deformities related to radiation-induced capsular contracture. Patients with unfavourable outcomes after TE placement and RT, instead, can be directly switched to autologous reconstruction.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
乳房切除术后放疗(PMRT)在局部晚期乳腺癌的治疗中起主要作用;然而,在即刻组织扩张器乳房重建(ITEBR)中最合适的放疗时机仍不明确。
对2010年至2019年期间在意大利罗马的坎皮斯生物医学大学医院接受乳房切除术和胸后间隙ITEBR的所有女性进行回顾性研究。患者被分为三组:组织扩张器(TE)在位时接受PMRT的患者、对永久植入物(PI)进行PMRT的患者、未接受放疗的患者。分析并比较并发症和失败率。分析不良结局的潜在预测因素。
在10年期间,183例患者接受了胸后间隙ITEBR(55例PMRT-TE,50例PMRT-PI,78例未接受PMRT)。除新辅助化疗和放疗外,三组在患者和治疗相关因素方面匹配良好(p>0.05)。平均随访时间分别为4.58年、7年和5.75年。对TE或PI进行放疗均与失败以及转为自体手术独立相关(p<0.0001)。对TE进行放疗时失败率显著更高(p=0.03)。PMRT与严重包膜挛缩的发生相关(p<0.00001),在植入物更换后进行放疗时几率更高(p=0.04)。BMI增加与失败显著相关。
当对TE进行PMRT时,失败风险更高(OR 2.77);当对PI进行放疗时,重建更可能受严重包膜挛缩影响(OR 2.7)。然而,考虑到与PMRT相关的严重包膜挛缩的总体风险高于失败风险,我们认为应在TE在位时进行放疗。实际上在植入物更换时进行适当的包膜成形术可纠正与放射性包膜挛缩相关的畸形。相反,TE植入和放疗后结局不佳的患者可直接转为自体重建。
证据等级IV:本刊要求作者为每篇文章指定证据等级。有关这些循证医学评级的完整描述,请参阅目录或作者在线指南www.springer.com/00266 。